The EU announced on the 28th June 2004 a contribution of €9 million to the “Vigilance against Viral Resistance” (VIRGIL) project.
This project intends to start by studying viral hepatitis and influenza, and then broadening to other viruses.
The network will be based on research and technological platforms to monitor existing, and anticipate future, drug resistance.
The VIRGIL project is coordinated by Lyon’s INSERM research centre and gathers 55 key European field experts from 12 countries, including 7 partners from industry.
